You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XFOR Sale Disclosure
Kirske David · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$33.66K
Kirske David Chief Financial Officer
XFOR
X4 Pharmaceuticals
XFOR
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
XFOR daily price context
Close on/before transaction
$2.83
Oct 1, 2026
First close after public filing
$2.77
Oct 6, 2026
30-day return after filing
+16.97%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,767 shares @ $2.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001501697-26-000078
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$33.66K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| X4 Pharmaceuticals, Inc XFOR Current | Sale | Oct 1, 2026 | $33.66K |